STC2 and osteosarcoma: In this study, we developed a novel ER stress-related prognostic signature (ERSRPS) for osteosarcoma based on five differentially-expressed ERSRGs; among them, Stanniocalcin 2 (STC2) was determined to be the risk gene associated with an unfavorable prognosis in ER stress signaling.